Strensiq Average Annual Price Of $285,000 Has Room To Grow
Alexion expects high proportion of hypophosphatasia patients initiating treatment will be infants or young children; sales likely to increase over time because of weight-based dosing.
You may also be interested in...
Alexion plans to use voucher for one of its own products and might be targeting its next-generation version of blockbuster Soliris.
Real-World Evidence: CDC Prioritizing Populations, Outcomes For COVID-19 Vaccine Effectiveness Studies
Strategy for assessing how the earliest vaccines to reach market perform beyond clinical trials includes leveraging existing surveillance and data platforms, and employing a diversity of study approaches, CDC epidemiologist says; high-priority areas for study include protection against symptomatic illness among health care workers and prevention of severe disease in the elderly.
Biologics license application is preferred route to market, but if emergency authorization is given it should happen with full transparency and be communicated in a clear manner to strengthen public confidence, National Vaccine Advisory Committee says.